Thyroid cancer, the most common cancer of the endocrine glands, is the fastest rising cancer in women and second fastest rising in men in the U.S. Thyroid cancer is a cancer originating from follicular or parafollicular thyroid cells. These cells give rise to both well-differentiated cancers (i.e., papillary and follicular) and analastic thyroid cancer. The second cell type, the C or parafollicular cell, produces the hormone calcitonin and is the cell of origin for medullary thyroid carcinoma.
Due to the heterogeneity of the disease there is an acknowledged difficulty in identifying hereditary and genetic risk factors for the diseases with conventional methods. Now, researchers from Cleveland Clinic state that they have identified a new gene associated with Cowden syndrome (CS), an inherited condition that carries a high risk of thyroid cancer. The team state that this new cancer-predisposing gene will facilitate predictive genetic testing, risk assessment, genetic counseling, and clinical management of thyroid cancer and CS. The opensource study is published in the American Journal of Human Genetics.
The current shows that normal thyroid cells expressing mutated SEC23B grew faster, formed larger colonies, invaded more aggressively, and were able to survive in a very stressful microenvironment, all major hallmarks of cancer. The researchers searched their clinical database for accrued CS- affected families. Eligible families consisted of at least one unaffected and two affected family members. To identify the SEC23B gene, a multi-generation CS-affected family (family 616) presenting with different types of CS-related cancers, particularly thyroid cancer, across four generations was selected.
Results show that SEC23B mutations are present in up to 3 percent of unrelated Cowden syndrome patients and in 4 percent of patients with non-syndromic thyroid cancer. Data findings show that approximately 50 percent of Cowden syndrome patients tested negative for all known genetic mutations.
The team surmise that their not only identified a novel cancer-predisposing gene, particularly in thyroid cancer, it also highlights how cellular stress responses can be hijacked by cancer cells to promote their survival. For the future, the researchers have also linked this gene to anemia and as they cannot ascertain anemia-related clinical phenotypes unrelated to cancer in these individuals, they plan to clarify this.
Source: Cleveland Clinic
Michelle Petersen is the founder of Healthinnovations, having worked in the health and science industry for over 21 years, which includes tenure within the NHS and Oxford University. Healthinnovations is a publication that has reported on, influenced, and researched current and future innovations in health for the past decade.
Michelle has been picked up as an expert writer for Informa publisher’s Clinical Trials community, as well as being listed as a blog source by the world’s leading medical journals, including the acclaimed Nature-Springer journal series.
Healthinnovations is currently indexed by the trusted Altmetric and PlumX metrics systems, respectively, as a blog source for published research globally. Healthinnovations is also featured in the world-renowned BioPortfolio, BioPortfolio.com, the life science, pharmaceutical and healthcare portal.
Most recently the Texas A&M University covered The Top 10 Healthinnovations series on their site with distinguished Professor Stephen Maren calling the inclusion of himself and his team on the list a reflection of “the hard work and dedication of my students and trainees”.
Michelle Petersen’s copy was used in the highly successful marketing campaign for the mega-hit film ‘Jumanji: The Next Level, starring Jack Black, Karen Gilian, Kevin Hart and Dwayne ‘The Rock’ Johnson. Michelle Petersen’s copywriting was part of the film’s coverage by the Republic TV network. Republic TV is the most-watched English language TV channel in India since its inception in 2017.
An avid campaigner in the fight against child sex abuse and trafficking, Michelle is a passionate humanist striving for a better quality of life for all humans by helping to provide traction for new technologies and techniques within healthcare.